An ex vivo model to evaluate DNA damage by comet assay in breast-cancer tissue
Authors:
- Catalina García-VielmaCGCatalina García-Vielma
- Elva Irene Cortés-GutiérrezECElva Irene Cortés-Gutiérrez
- Irma Edith Carranza-TorresICIrma Edith Carranza-Torres
- Nancy Elena Guzmán-DelgadoNGNancy Elena Guzmán-Delgado
- Ricardo Martín Cerda-FloresRCRicardo Martín Cerda-Flores
- Pilar Carranza-RosalesPCPilar Carranza-Rosales
- 19 May 2025
- journal article
- Published by Taylor & Francis in Toxicology Mechanisms and Methods
- Vol. 35 (8) , 1003-1010
Abstract
Single cell gel electrophoresis (comet assay) is a research tool known for its use in the assessment of DNA damage in which peripheral blood lymphocytes are used as a cellular model. The objective of this study was to adapt the comet assay to fresh normal and tumor breast tissue explants to assess DNA damage. Representative samples were obtained from nine patients with infiltrating ductal adenocarcinoma during the time of surgical intervention for the resection of the tumor. One hundred micrometer thick explants were prepared from normal and tumor breast tissue using a tissue slicer. Explants were harvested into six-well microplates with 4 mL of sterile serum-free Dulbecco's modified Eagle's medium/Ham's F12 medium at 4 °C for immediate processing of the comet assay. The results indicated that the comet assay can be used to analyze DNA damage in tumors and healthy breast tissue in an ex vivo model that allows visualization of the level of DNA damage. Compared to non-tumor cells, DNA damage in breast cancer was significantly increased (p < 0.05); furthermore, DNA damage was higher in samples treated with H2O2 (positive control) and confirmed that cells in the explants can interact with the chemicals tested, as well as the functionality of the technique. The comet assay using fresh tissue explants represents an alternative tool with potential to identify DNA damage in tumor tissue and to study new drugs to personalize the use of DNA-damaging therapies.Keywords
Funding Information
- Fondo de Investigación en Salud. Coordinación de Investigación en Salud del Instituto Mexicano del Seguro Social (FIS/IMSS/PROT/G14/1298)
This publication has 68 references indexed in Scilit:
- Exploring the Potential of PEG‐Heparin Hydrogels to Support Long‐Term Ex Vivo Culture of Patient‐Derived Breast Explant TissuesAdvanced Healthcare Materials, 2023
- A patient‐derived explant (PDE) model of hormone‐dependent cancerMolecular Oncology, 2018
- Symposium Overview: Genetic Polymorphisms in DNA Repair and Cancer RiskToxicology and Applied Pharmacology, 2002
- Loss of heterozygosity and allelic imbalance in apocrine metaplasia of the breast: microdissection microsatellite analysisThe Journal of Pathology, 2002
- Genetic regulation of ionizing radiation sensitivity and breast cancer riskEnvironmental and Molecular Mutagenesis, 2002
- Oxidative DNA damage and 8‐hydroxy‐2‐deoxyguanosine DNA glycosylase/apurinic lyase in human breast cancerMolecular Carcinogenesis, 2001
- Ongoing research to identify environmental risk factors in breast carcinomaCancer, 2000
- DecreasedBRCA1Expression Levels May Arrest the Cell Cycle through Activation ofp53Checkpoint in Human Sporadic Breast TumorsBiochemical and Biophysical Research Communications, 1998
- DNA repair proficiency in breast cancer patients and their first-degree relativesInternational Journal of Cancer, 1997
- DNA damage in nasal respiratory epithelium from children exposed to urban pollutionEnvironmental and Molecular Mutagenesis, 1997